US Patent Issued to GlaxoSmith Kline Intellectual Property Development on April 21 for "Antigen binding proteins" (British, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,639, issued on April 21, was assigned to GlaxoSmith Kline Intellectual Property Development Ltd. (Stevenage, Great Britain).

"Antigen binding proteins" was invented by Erding Hu (Collegeville, Pa.) and Matthew Gardener (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antigen binding proteins. More particularly the present disclosure relates to pregnancy associated plasma protein-A (PAPPA) binding proteins, even more particularly PAPPA binding proteins that inhibit cleavage of insulin like growth factor binding protein-2 (IGFBP-2), insulin like growth factor binding protein-4 (IGFBP-4) and in...